PNC Financial Services Group’s Pyxis Oncology PYXS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$15.1K Hold
6,500
– – ﹤0.01% 3989
2026
Q2
$19.6K Hold
6,500
– – ﹤0.01% 3792
2026
Q1
$9.49K Buy
+6,500
New +$9.8K ﹤0.01% 3976
2023
Q3
– Sell
-100
Closed -$256 – 4718
2023
Q2
$256 Hold
100
– – ﹤0.01% 4646
2023
Q1
$401 Buy
+100
New +$200 ﹤0.01% 4546

Other funds holding PYXS

PNC Financial Services Group's PYXS Position: Q3 2026 in Review

PNC Financial Services Group held its Pyxis Oncology (PYXS) position steady in Q3 2026 at 6,500 shares worth $15.1K. The position accounts for ﹤0.01% of the portfolio, ranked #3989.

PNC Financial Services Group first reported a position in PYXS in Q1 2023 and has held it in 5 quarters since. The position peaked at $19.6K in Q2 2026. 101 funds tracked by Wall St. Rank hold PYXS as of Q3 2026.

  • PNC Financial Services Group held 6,500 shares of Pyxis Oncology worth $15.1K as of Q3 2026.
  • PNC Financial Services Group left its Pyxis Oncology share count unchanged in Q3 2026.
  • Pyxis Oncology made up ﹤0.01% of PNC Financial Services Group's portfolio in Q3 2026, its #3989 holding.
  • PNC Financial Services Group first reported a position in Pyxis Oncology in Q1 2023 and has held it in 5 quarters since.
  • PNC Financial Services Group's Pyxis Oncology position peaked at $19.6K in Q2 2026.
  • 101 funds tracked by Wall St. Rank held Pyxis Oncology as of Q3 2026.

Based on PNC Financial Services Group's 13F filing for Q3 2026, filed 6 Nov 2026.